Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 56606
Gene Symbol: SLC2A9
SLC2A9 		0.400 GeneticVariation disease GWASCAT Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes. 25646370 2016
Entrez Id: 56606
Gene Symbol: SLC2A9
SLC2A9 		0.400 GeneticVariation disease GWASCAT Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. 23263486 2013
Entrez Id: 56606
Gene Symbol: SLC2A9
SLC2A9 		0.400 GeneticVariation disease GWASDB Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. 23263486 2013
Entrez Id: 56606
Gene Symbol: SLC2A9
SLC2A9 		0.400 GeneticVariation disease GWASDB Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele. 21768215 2011
Entrez Id: 56606
Gene Symbol: SLC2A9
SLC2A9 		0.400 GeneticVariation disease GWASCAT Identification of low-frequency variants associated with gout and serum uric acid levels. 21983786 2011
Entrez Id: 56606
Gene Symbol: SLC2A9
SLC2A9 		0.400 GeneticVariation disease GWASDB Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. 20884846 2010
Entrez Id: 56606
Gene Symbol: SLC2A9
SLC2A9 		0.400 GeneticVariation disease GWASCAT Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. 20884846 2010
Entrez Id: 56606
Gene Symbol: SLC2A9
SLC2A9 		0.400 Biomarker disease CTD_human SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. 18327256 2008
Entrez Id: 56606
Gene Symbol: SLC2A9
SLC2A9 		0.400 GeneticVariation disease GWASDB SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. 18327257 2008
Entrez Id: 56606
Gene Symbol: SLC2A9
SLC2A9 		0.400 GeneticVariation disease GWASDB Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. 18834626 2008
Entrez Id: 56606
Gene Symbol: SLC2A9
SLC2A9 		0.400 Biomarker disease CTD_human SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. 18327257 2008
Entrez Id: 56606
Gene Symbol: SLC2A9
SLC2A9 		0.400 GeneticVariation disease GWASDB Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. 18179892 2008
Entrez Id: 56606
Gene Symbol: SLC2A9
SLC2A9 		0.400 GeneticVariation disease GWASDB SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. 18327256 2008
Entrez Id: 56606
Gene Symbol: SLC2A9
SLC2A9 		0.400 GeneticVariation disease GWASDB The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. 17997608 2007
Entrez Id: 929
Gene Symbol: CD14
CD14 		0.310 Biomarker disease BEFREE In this study, we found that the proportion of CD14-positive PBMCs was decreased in gout patients when compared with healthy controls and the serum sCD14 level was also considerably decreased in gout patients in comparison to healthy controls. 31312662 2019
Entrez Id: 3553
Gene Symbol: IL1B
IL1B 		0.310 Biomarker disease CTD_human Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout. 26462562 2015
Entrez Id: 929
Gene Symbol: CD14
CD14 		0.310 Biomarker disease CTD_human Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout. 26462562 2015
Entrez Id: 3553
Gene Symbol: IL1B
IL1B 		0.310 GeneticVariation disease BEFREE Results of the present study suggest that polymorphisms of the IL-1beta promoter and IL-1beta exon 5 are not related to gout patients in central Taiwan. 14661113 2005
Entrez Id: 7498
Gene Symbol: XDH
XDH 		0.300 Biomarker disease CTD_human Potential cow milk xanthine oxidase inhibitory and antioxidant activity of selected phenolic acid derivatives. 29071757 2018
Entrez Id: 80216
Gene Symbol: ALPK1
ALPK1 		0.300 Biomarker disease CTD_human Enhanced alpha-kinase 1 accelerates multiple early nephropathies in streptozotocin-induced hyperglycemic mice. 27542954 2016
Entrez Id: 22900
Gene Symbol: CARD8
CARD8 		0.300 Biomarker disease CTD_human Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout. 26462562 2015
Entrez Id: 126133
Gene Symbol: ALDH16A1
ALDH16A1 		0.300 Biomarker disease CTD_human Identification of low-frequency variants associated with gout and serum uric acid levels. 21983786 2011
Entrez Id: 3557
Gene Symbol: IL1RN
IL1RN 		0.300 Therapeutic disease CTD_human Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. 18403674 2008
Entrez Id: 3251
Gene Symbol: HPRT1
HPRT1 		0.130 GeneticVariation disease LHGDN HPRTSardinia: a new point mutation causing HPRT deficiency without Lesch-Nyhan disease. 16216473 2006
Entrez Id: 3251
Gene Symbol: HPRT1
HPRT1 		0.130 GeneticVariation disease BEFREE A C-to-A substitution at base 73 in exon 2, which predicted proline 25 to threonine, was detected in the gout patient (designated HPRT Yonago). 8112742 1994